Condition: Chronic Total Occlusion · Coronary Artery Disease · Sponsor: Ruijin Hospital
This study aims to assess the risk factors and evaluate the long-term outcomes of patients with coronary chronic total occlusion (CTO) treated with percutaneous coronary intervention or medical treatment.
This description comes directly from the study's public registry record.
Fenghua Ding, PhD, MD · 0086 021 64370045 · ruijindfh@126.com
Always discuss trial participation with your own doctor first.
| Ruijin Hospital, Shanghai Jiao Tong University School of Medicine | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06137521